BioPharmaChem Sector convenes to discuss opportunities for sustainable development of the biopharma ecosystem at BioPharmaChem Impact 2025
During the conference, BPCI officially launched their BioPharma Business Services (BBS) strategy, with the aim of positioning Ireland as a hub for global services by leveraging Ireland’s position as a leading manufacturing location and further diversifying and strengthening the industry ecosystem in the country. BBS is one of the fastest growing industry segments, expected to grow by 10% CAGR by 2027.
Aoife Allen, VP Finance & Global Business Services at Pfizer and Chair of BPCI’s BioPharma Business Services Steering Committee, said: “Today, nearly 9,500 professionals, representing close to 20% of the total BioPharmaChem employment in Ireland, drive a dynamic services sector that has evolved from primarily managing corporate finance to spearheading areas like medical information, clinical trials, and supply chain management. Our new strategy focuses on value stream enhancement, talent development, cutting-edge digital and AI infrastructure, and a vibrant ecosystem, to position Ireland as the global leader in innovative, high-value biopharma services. This evolution positions Ireland not only as a key player in the industry but as a central orchestrator of enterprise-wide solutions, unlocking new pathways for growth, collaboration, and breakthroughs on the world stage.”
The theme of this year’s conference, ‘Realising the potential of our ecosystem’ highlights the BioPharmaChem sector’s commitment to innovation and collaboration. BioPharmaChem Impact brings together leading experts to examine the economic and global trends shaping the BioPharmaChem ecosystem, the sector's evolving approach to sustainability, the integration of AI in manufacturing, and the growing collaboration between industry and academia
Joyce Fitzharris, Chair of BioPharmaChem Ireland and President of SK pharmteco said: “The BioPharmaChem Ireland Impact 2025 conference is a powerful demonstration of the scale, strength, and resilience of our ecosystem. It brings together experts from industry, academia, and research institutions to collectively address the pressing challenges of today and tomorrow. With a strong multinational presence, a growing indigenous base, and a vibrant CDMO network, Ireland’s BioPharmaChem sector is driving progress across traditional API manufacturing, biotech, and advanced therapeutics such as cell and gene therapy. This conference demonstrates that through true collaboration, grounded in regulatory excellence, a skilled workforce, and future-focused ambition, we are shaping a globally competitive future."
BPCI is immensely grateful to the BioPharmaChem Impact 2025 sponsors. They include platinum sponsors EY and SSPC; Gold sponsors Brightbeam, Camida, Chemco, DHL Supply Chain and Innopharma; and silver sponsors BioPharmaChem Skillnet, BioPharmaChem Ireland Apprenticeships, Enterprise Ireland, IDA Ireland, Indaver, Micro-Bio, Orion GXP Consulting and WuXi Biologics.
